Related Experiment Video
Updated: Sep 11, 2025
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
4.0K
The HighLife transcatheter mitral valve replacement system: A novel two-component platform
Michail Penteris1, Konstantinos Lampropoulos2
1Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Summary
The HighLife transcatheter mitral valve replacement system offers a new treatment for severe mitral regurgitation in high-risk patients. Early studies show high success and reduced regurgitation, expanding options for previously untreatable cases.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Device Technology
Background:
- Severe mitral regurgitation (MR) is common and often undertreated, especially in patients unsuitable for surgery or transcatheter edge-to-edge repair (M-TEER).
- Existing transcatheter mitral valve replacement (TMVR) options have limitations regarding patient selection and delivery methods.
Purpose of the Study:
- To evaluate the feasibility and early outcomes of the HighLife transcatheter mitral valve replacement (TMVR) system.
- To assess the safety, efficacy, and procedural characteristics of the HighLife TMVR system in patients with severe mitral regurgitation.
Main Methods:
- The HighLife system utilizes a two-component design (subannular ring and self-expanding bioprosthetic valve) delivered via transfemoral arterial and transseptal venous access.
- Early clinical data from first-in-human and feasibility studies were analyzed, focusing on technical success, MR reduction, and clinical outcomes.
Main Results:
- High technical success rates were achieved in early studies.
- Significant reduction in mitral regurgitation and favorable short- to mid-term clinical outcomes were observed.
- Device iterations have expanded applicability to a wider range of anatomies, addressing limitations like large annulus size and LVOT obstruction.
Conclusions:
- The HighLife TMVR system demonstrates promising early results for treating severe mitral regurgitation in high-risk patients.
- The system's unique design allows for circumferential anchoring without requiring annular calcification or transapical access.
- Further clinical trials are necessary to confirm long-term safety, durability, and efficacy, potentially establishing HighLife as a viable TMVR option.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
01:25Mitral Regurgitation III: Medical Management
30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
01:22Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
01:22Mitral Stenosis I: Introduction
35
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
35
01:27Mitral Valve Prolapse I: Introduction
43
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
43
01:20Mitral Regurgitation I: Introduction
55
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
55